Consistent with this, previous work had suggested that disruption of the PCNA binding domain of P21 has no major effect on the S phase of the cell cycle even in human cancer cells, in contrast to its N-terminal CDK inhibitory one (Nakanishi et al., 1995; Ogryzko et al., 1997). The gene discussed is PCNA; the disease is cancer.